Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia

British Journal of Pharmacology

Volumn 161, Issue 3, 2010, Pages 668-679

  Chan, Su Jing ^a   Wong, W S Fred ^a   Wong, Peter T H ^a   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

andrographolide; anti inflammation; cerebral ischaemia; stroke

Indexed keywords

ANDROGRAPHOLIDE; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR TRANSPORT; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN TRANSPORT; RAT; STROKE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DINOPROSTONE; DISEASE MODELS, ANIMAL; DITERPENES; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1BETA; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956326833     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00906.x     Document Type: Article

References (59)

1. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI (2009). In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immunopharmacol 9 : 313 318.
2. Adibhatla RM, Hatcher JF (2008). Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 7 : 243 253.
3. Akowuah GA, Zhari I, Mariam A, Yam MF (2009). Absorption of andrographolides from Andrographis paniculata and its effect on CCl(4)-induced oxidative stress in rats. Food Chem Toxicol 47 : 2321 2326.
4. Back T (1998). Pathophysiology of the ischemic penumbra - revision of a concept. Cell Mol Neurobiol 18 : 621 638.
5. Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM et al. (2009). A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med 179 : 657 665.
6. Barone FC (2009). Ischemic stroke intervention requires mixed cellular protection of the penumbra. Curr Opin Investig Drugs 10 : 220 223.
7. Barone FC, Feuerstein GZ (1999). Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19 : 819 834.
8. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN et al. (1997). Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28 : 1233 1244.
9. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 : 472 476.
10. Burgos RA, Seguel K, Perez M, Meneses A, Ortega M, Guarda MI et al. (2005). Andrographolide inhibits IFN-gamma and IL-2 cytokine production and protects against cell apoptosis. Planta Med 71 : 429 434.
11. Carretta MD, Alarcon P, Jara E, Solis L, Hancke JL, Concha II et al. (2009). Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation. Eur J Pharmacol 602 : 413 421.
12. Chamorro A, Hallenbeck J (2006). The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37 : 291 293.
13. Chen JX, Xue HJ, Ye WC, Fang BH, Liu YH, Yuan SH et al. (2009). Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol Pharm Bull 32 : 1385 1391.
14. Cho ML, Moon YM, Heo YJ, Woo YJ, Ju JH, Park KS et al. (2009). NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells. Immunol Lett 123 : 21 30.
15. Clemens JA, Stephenson DT, Smalstig EB, Dixon EP, Little SP (1997). Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke 28 : 1073 1080 discussion 1080-1071.
16. Dirnagl U, Iadecola C, Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 : 391 397.
17. Feigin VL (2005). Stroke epidemiology in the developing world. Lancet 365 : 2160 2161.
18. Garcia JH, Liu KF, Relton JK (1995). Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147 : 1477 1486.
19. Gunther A, Kuppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D et al. (2005). Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci 21 : 3189 3194.
20. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359 : 1317 1329.
21. He X, Li J, Gao H, Qiu F, Cui X, Yao X (2003). Six new andrographolide metabolites in rats. Chem Pharm Bull 51 : 586 589.
22. Iadecola C, Forster C, Nogawa S, Clark HB, Ross ME (1999). Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol 98 : 9 14.
23. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E et al. (2001). Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate- mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A 98 : 1294 1299.
24. Iruretagoyena MI, Sepulveda SE, Lezana JP, Hermoso M, Bronfman M, Gutierrez MA et al. (2006). Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 318 : 59 67.
25. Jiang X, Yu P, Jiang J, Zhang Z, Wang Z, Yang Z et al. (2009). Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur J Med Chem 44 : 2936 2943.
26. Lapchak PA (2002). Development of thrombolytic therapy for stroke: a perspective. Expert Opin Investig Drugs 11 : 1623 1632.
27. Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M et al. (2009). NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem 284 : 4473 4483.
28. Lin TP, Chen SY, Duh PD, Chang LK, Liu YN (2008). Inhibition of the epstein-barr virus lytic cycle by andrographolide. Biol Pharm Bull 31 : 2018 2023.
29. Lin FL, Wu SJ, Lee SC, Ng LT (2009). Antioxidant, antioedema and analgesic activities of Andrographis paniculata extracts and their active constituent andrographolide. Phytother Res 23 : 958 964.
30. Liu W, Hendren J, Qin XJ, Liu KJ (2009). Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Stroke 40 : 2526 2531.
31. Lu W (1995). Prospect for study on treatment of AIDS with traditional Chinese medicine. J Tradit Chin Med 15 : 3 9.
32. Mehta SL, Manhas N, Raghubir R (2007). Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54 : 34 66.
33. Muir KW, Tyrrell P, Sattar N, Warburton E (2007). Inflammation and ischaemic stroke. Curr Opin Neurol 20 : 334 342.
34. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 : 1436 1442.
35. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML et al. (2004). Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 : 987 991.
36. Qin LH, Kong L, Shi GJ, Wang ZT, Ge BX (2006). Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases. Biol Pharm Bull 29 : 220 224.
37. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT (2006). Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37 : 889 893.
38. Roxas M, Jurenka J (2007). Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev 12 : 25 48.
39. Samson Y, Lapergue B, Hosseini H (2005). Inflammation and ischaemic stroke: current status and future perspectives. Rev Neurol 161 : 1177 1182.
40. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5 : 554 559.
41. Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G (1997). Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 28 : 382 386.
42. Stoll G, Jander S, Schroeter M (1998). Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56 : 149 171.
43. Suebsasana S, Pongnaratorn P, Sattayasai J, Arkaravichien T, Tiamkao S, Aromdee C (2009). Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 32 : 1191 1200.
44. Sulaiman MR, Zakaria ZA, Abdul Rahman A, Mohamad AS, Desa MN, Stanslas J et al. (2010). Antinociceptive and antiedematogenic activities of andrographolide isolated from Andrographis paniculata in animal models. Biol Res Nurs 11 : 293 301.
45. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981). Focal cerebral ischaemia in the rat: 1. description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1 : 53 60.
46. Thisoda P, Rangkadilok N, Pholphana N, Worasuttayangkurn L, Ruchirawat S, Satayavivad J (2006). Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation. Eur J Pharmacol 553 : 39 45.
47. Varma A, Padh H, Shrivastava N (2009). Andrographolide: a new plant-derived antineoplastic entity on horizon. Evid Based Complement Alternat Med Epub ahead of print
48. Wang T, Liu B, Zhang W, Wilson B, Hong JS (2004). Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation. J Pharmacol Exp Ther 308 : 975 983.
49. Wang Q, Tang XN, Yenari MA (2007a). The inflammatory response in stroke. J Neuroimmunol 184 : 53 68.
50. Wang YJ, Wang JT, Fan QX, Geng JG (2007b). Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis. Cell Res 17 : 933 941.
51. Woo AY, Waye MM, Tsui SK, Yeung ST, Cheng CH (2008). Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury. J Pharmacol Exp Ther 325 : 226 235.
52. Wood PL (1995). Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 17 : 242 248.
53. Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X et al. (2004). Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 173 : 4207 4217.
54. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K (1995). Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26 : 676 680 discussion 681.
55. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL (1998). Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 9 : 2131 2134.
56. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96 : 13496 13500.
57. Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T (2005). Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 : 2220 2225.
58. Zhang L, Chopp M, Jia L, Cui Y, Lu M, Zhang ZG (2009a). Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats. J Cereb Blood Flow Metab 29 : 1816 1824.
59. Zhang Z, Jiang J, Yu P, Zeng X, Larrick JW, Wang Y (2009b). Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment. J Transl Med 7 : 62.